Pro Research Updates
Our research updates, often shorter in length, are conveyed through initial and ongoing coverage of our catalog of stocks. With thousands of original research pieces and updates under our belt, we have an archival system of keeping the history of our coverage intact and easy to find. For examples of how you will receive this research please see a few case studies showing the chronology of a few notable stocks.
Below you can find the most recent stocks that we have issued original research on, or updates to original research.
Log in below with your Premium Account to see the most recent coverage.
The FULL list of Spotlight Research can be found HERE, which has years of coverage and updates – all archived for your reference. Feel free to use the Advanced Filter at that page to quickly find coverage on stock of interest.
Latest Stock Coverage
Branchout Food Inc. (NASDAQ:BOF) ($4.39; $67.2M market cap) announced Q2 revenues:
Q2 sales of approximately $4.5 million vs. $3.3 million in the prior year, ahead of analyst estimate of $4.0 million
Crunchy Fruit Chips became an approximately $8 million annual everyday program across 309 warehouse clubs, with shipments beginning in September.
BranchOut secured an additional estimated $2 mi...
Koil Energy Solutions, Inc. (OTCQB:KLNG) ($2.55; $30.4M market cap) announced Q2 2026 results:
Q2 sales of $9.2 million vs. $5.2 million in the prior year
Q2 2026 EPS: $0.05 vs. $0.01 in the prior year
KOIL awarded a major subsea umbilical handling, spooling and storage project requiring two large carousels.
KOIL secured a new $5 million lending facility and acquired a 3,500-metric-ton mo...
Fitlife Brands, Inc. (NASDAQ:FTLF) ($10.26; $96.4M market cap) announced Q2 2026 results:
Q2 sales of $26.5 million vs. $16.1 million in the prior year, ahead of analyst estimates of $26.0 million
Q2 2026 EPS: $0.20 vs. $0.18 in the prior year, in line with analyst estimates of $0.20
Irwin’s Amazon business reached an approximately $11 million annual revenue run rate by quarter-end....
Tecogen Inc. (NYSE:TGEN) ($4.01; $120.0M market cap) announced Q2 2026 results:
Q2 sales of $5.75 million vs. $7.29 million in the prior year, below analyst estimate of $5.98 million
Q2 2026 EPS: loss of $(0.07) vs. loss of $(0.06) in the prior year, ahead of analyst estimate of a loss of $(0.08)
Non-data-center backlog was approximately $8 million, with at least $2 million of additional or...
Cipher Pharmaceuticals, Inc. (OTC:CPHRF) (TSX:CPH) ($12.80; $456.2M market cap) announced Q2 2026 results:
Q2 sales of $12.1 million vs. $13.4 million in the prior year, below analyst estimates of $13.6 million
Q2 2026 EPS: $0.15 vs. $0.22 in the prior year, below analyst estimates of $0.19
Natroba™ revenue fell 19% to $6.3 million, primarily due to reduced Medicaid patient coverage....
Viewing page 1 of 4|Next Page